Christopher Patusky - 15 Dec 2025 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role
Director
Signature
/s/ John S. Hess, Jr. under Power of Attorney
Issuer symbol
UTHR
Transactions as of
15 Dec 2025
Net transactions value
-$394,154
Form type
4
Filing time
16 Dec 2025, 16:30:51 UTC
Previous filing
28 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
PATUSKY CHRISTOPHER Director C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING /s/ John S. Hess, Jr. under Power of Attorney 16 Dec 2025 0001231427

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise $101,800 +1,000 +67% $101.80 2,490 15 Dec 2025 Direct
transaction UTHR Common Stock Sale $495,954 -1,000 -40% $495.95 1,490 15 Dec 2025 Direct F1
holding UTHR Common Stock 1,100 15 Dec 2025 by Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Stock Option Options Exercise $0 -1,000 -20% $0.000000 3,910 15 Dec 2025 Common Stock 1,000 $101.80 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $495.64 to $496.09. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.